Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Muscarinic Receptor Antagonists as a Therapy for Diabetic Neuropathy

NCT03050827 is registered in ClinicalTrials.gov with Eastern Virginia Medical School as lead sponsor.

NCT NCT03050827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03050827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Muscarinic Receptor Antagonists as a Therapy for Diabetic Neuropathy
Lead sponsor
Eastern Virginia Medical School
Phase
Phase 3
Overall status
Completed
Start date
May 1, 2014
Completion date
December 31, 2017
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic; neuropathic, polyneuropathy (manifestation)